首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   567篇
  免费   81篇
  国内免费   1篇
  649篇
  2021年   7篇
  2018年   5篇
  2017年   6篇
  2016年   14篇
  2015年   19篇
  2014年   21篇
  2013年   19篇
  2012年   35篇
  2011年   21篇
  2010年   19篇
  2009年   18篇
  2008年   16篇
  2007年   27篇
  2006年   22篇
  2005年   18篇
  2004年   21篇
  2003年   24篇
  2002年   15篇
  2001年   17篇
  2000年   29篇
  1999年   21篇
  1998年   14篇
  1997年   8篇
  1996年   8篇
  1995年   8篇
  1994年   15篇
  1993年   10篇
  1992年   8篇
  1991年   10篇
  1990年   8篇
  1989年   14篇
  1988年   9篇
  1987年   8篇
  1986年   6篇
  1985年   7篇
  1984年   8篇
  1983年   5篇
  1981年   7篇
  1980年   8篇
  1977年   5篇
  1976年   11篇
  1975年   5篇
  1974年   5篇
  1973年   9篇
  1972年   6篇
  1971年   5篇
  1970年   4篇
  1969年   7篇
  1968年   4篇
  1965年   5篇
排序方式: 共有649条查询结果,搜索用时 0 毫秒
191.
192.
193.
194.
BACKGROUND: We evaluated a clinical-grade protocol for the manufacture of mature DC from CD14 + precursors derived from normal donors and patients suffering from CML and stage IV malignant melanoma. We manufactured six products for CML patients and five for melanoma patients and administered them as vaccines in phase I clinical trials. METHODS: We isolated CD 14+ cells from apheresis products by immunomagnetic separation and incubated them in X-VIVO 15' medium supplemented with human AB serum, GM-CSF and IL-4 for 7 days, and with additional tumor necrosis factor (TNF)-a, IL-lIf, IL-6 and prostaglandin E2 for 3 days. Some cells were electroporated and transfected with mRNA isolated from melanoma tissue. DC were characterized by flow cytometry for the expression of CD83, CD86 andCD14. RESULTS: CD14+ cells constituted 14.4+/-6.2% (mean + SD) of nucleated cells in apheresis products and 98.3+/- 3.6% of isolated cells. Normal DC and CML DC were 77.4+/-7.3% CD83+ and 93.5+/- 7.0% CD86+.Corresponding values for electroporated DC from melanoma patients were 66.1 + 7.2% and 94.1 + 7.8%. The yield of CD83+ DC from isolated CD14+ cells was 18.1 + 7.2% for normal and CML patients and 9.8 + 3.7% for melanoma patients. DC viability was 92.7 + 5.8%; after cryopreservation and thawing it was 77+/-13.5%. DISCUSSION: Our method yielded viable and mature DC free of bacteria and mycoplasma. This robust and reproducible method provides cells of consistent phenotype and viability. Cryopreservation in single-dose aliquots allows multiple DC vaccine doses to be manufactured from a single apheresis product.  相似文献   
195.
196.
197.
Cysteamine and its dimeric form cystamine have been applied to the rat striatum by local injection. Both compounds resulted in a dose-dependent decrease of somatostatin levels. Maximal reduction of somatostatin (by about 50%) was obtained at a dose of 50 micrograms of cysteamine or cystamine after about 6 h. All three molecular weight forms of somatostatin--somatostatin-14, somatostatin-28, and the 13,000 molecular weight form of somatostatin--were reduced, as shown by size exclusion HPLC. Injection of radiolabeled cystamine revealed a fast conversion of the compound to cysteamine, suggesting it is active in the monomeric form. The levels of neuropeptide Y, which is colocalized with somatostatin in striatal neurons, failed to be changed by local or intraperitoneal injection of cysteamine, suggesting that this treatment does not affect vesicles of somatostatin/neuropeptide Y neurons.  相似文献   
198.

Background

The importance of effective clinical teaching for the quality of future patient care is globally understood. Due to recent changes in graduate medical education, new tools are needed to provide faculty with reliable and individualized feedback on their teaching qualities. This study validates two instruments underlying the System for Evaluation of Teaching Qualities (SETQ) aimed at measuring and improving the teaching qualities of obstetrics and gynecology faculty.

Methods and Findings

This cross-sectional multi-center questionnaire study was set in seven general teaching hospitals and two academic medical centers in the Netherlands. Seventy-seven residents and 114 faculty were invited to complete the SETQ instruments in the duration of one month from September 2008 to September 2009. To assess reliability and validity of the instruments, we used exploratory factor analysis, inter-item correlation, reliability coefficient alpha and inter-scale correlations. We also compared composite scales from factor analysis to global ratings. Finally, the number of residents'' evaluations needed per faculty for reliable assessments was calculated. A total of 613 evaluations were completed by 66 residents (85.7% response rate). 99 faculty (86.8% response rate) participated in self-evaluation. Factor analysis yielded five scales with high reliability (Cronbach''s alpha for residents'' and faculty): learning climate (0.86 and 0.75), professional attitude (0.89 and 0.81), communication of learning goals (0.89 and 0.82), evaluation of residents (0.87 and 0.79) and feedback (0.87 and 0.86). Item-total, inter-scale and scale-global rating correlation coefficients were significant (P<0.01). Four to six residents'' evaluations are needed per faculty (reliability coefficient 0.60–0.80).

Conclusions

Both SETQ instruments were found reliable and valid for evaluating teaching qualities of obstetrics and gynecology faculty. Future research should examine improvement of teaching qualities when using SETQ.  相似文献   
199.
200.
Summary Four experiments are described in which the uptake patterns of various crop species were shown to enhance the solubilization of alkaline rock phosphates. In most cases, such enhancements resulted from soil acidification brought about by the alkaline uptake patterns. In one case, the enhancement may have stemmed primarily from a high Ca-uptake rate, which might be responsible for a shift in mass-action equilibria favoring the solubilization of rock phosphates. High uptake of Ca is expected to serve two purposes: 1. it acts in creating alkaline uptake patterns causing a decline in soil pH, and 2. it promotes a shift in mass-action equilibria.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号